Skowronski, D. M., Febriani, Y., Ouakki, M., Setayeshgar, S., El Adam, S., Zou, M., Talbot, D., Prystajecky, N., Tyson, J. R., Gilca, R., Brousseau, N., Deceuninck, G., Galanis, E., Fjell, C. D., Sbihi, H., Fortin, E., Barkati, S., Sauvageau, C., Naus, M., Patrick, D. M., Henry, B., Hoang, L. M. N., De Wals, P., Garenc, C., Carignan, A., Drolet, M., Jassem, A. N., Sadarangani, M., Brisson, M., Krajden, M., & De Serres, G. (2022). two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada. Clinical infectious diseases, 75, 1980–1992. http://access.bl.uk/ark:/81055/vdc_100171887736.0x000022